SCHEMBL5491008

SCHEMBL5491008

O=C(Nc1ccccc1)c1cccc(-c2cccc3ccccc23)c1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DEGS1 O15121 1/20 0.60
NR1H4 Q96RI1 1/20 0.57
PLG P00747 2/20 0.56
KLK1 P06870 2/20 0.56
KLK6 Q92876 2/20 0.56
PLAU P00749 1/20 0.55
PLAT P00750 1/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
CHRNB2 P17787 2/20 0.54
CHRNB4 P30926 2/20 0.54
CHRNA3 P32297 2/20 0.54
CHRNA4 P43681 2/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX12 P18054 1/20 0.54
LMNA P02545 2/20 0.53
KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31150345 0.82 DEGS1 (0.78) DEGS1NR1H4NPC1RAB9AMEN1
SCHEMBL368228 0.82 DEGS1 (0.78) DEGS1NR1H4NPC1RAB9AMEN1
SCHEMBL11426057 0.82 CYP3A4 (0.58) DEGS1NR1H4NPC1RAB9AMEN1
SCHEMBL8438773 0.81 PLG (0.74) DEGS1PLGKLK1KLK6NPC1
SCHEMBL2534284 0.81 NR4A1 (0.63) MEN1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL7067826 0.81 MEN1 (0.71) NPC1RAB9AMEN1KMT2ACHRNB2
SCHEMBL5494830 0.78 MCL1 (0.71) DEGS1NPC1RAB9AMEN1KMT2A
SCHEMBL2466597 0.77 MEN1 (0.65) DEGS1NR1H4PLGKLK1KLK6
SCHEMBL28323302 0.76 KDM4E (0.50) MEN1KMT2AKDM4EHPGDHSD17B10
SCHEMBL845143 0.76 TERT (0.80) KLK1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328507-B1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS UNIV NEW YORK STATE RES FOUND (US) 2007-03-14 EP disclosed
CN-1249019-C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents NEW YORK STATE UNIVERSITY RES (US) 2006-04-05 CN disclosed
CN-1249019-C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents NEW YORK STATE UNIVERSITY RES (US) 2006-04-05 CN disclosed
CN-1468210-A Naphthylsalicylanilides as antimicrobial and antiinflammatory agents ŦԼ������ѧ�о������ 2004-01-14 CN disclosed
CN-1468210-A Naphthylsalicylanilides as antimicrobial and antiinflammatory agents ŦԼ������ѧ�о������ 2004-01-14 CN disclosed
EP-1328507-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS The Research Foundation Of State University of New York (US) 2003-07-23 EP disclosed
EP-1328507-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS The Research Foundation Of State University of New York (US) 2003-07-23 EP disclosed
US-6407288-B1 AS ANTIBACTERIAL AGAINST GRAM NEGATIVE AND GRAM POSITIVE BACTERIA AND AS ANTIINFLAMMATORY AGENTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-06-18 US disclosed
US-6407288-B1 AS ANTIBACTERIAL AGAINST GRAM NEGATIVE AND GRAM POSITIVE BACTERIA AND AS ANTIINFLAMMATORY AGENTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-06-18 US disclosed
US-6407288-B1 AS ANTIBACTERIAL AGAINST GRAM NEGATIVE AND GRAM POSITIVE BACTERIA AND AS ANTIINFLAMMATORY AGENTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-06-18 US disclosed
US-20020065322-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE 2002-05-30 US disclosed
US-20020065322-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE 2002-05-30 US disclosed
WO-2002028819-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2002-04-11 WO disclosed
WO-2002028819-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065322-A1 NAPHTHYLSALICYLANILIDES AS ANTIMICROBIAL AND ANTIINFLAMMATORY AGENTS PTGES3, FPR3, PTGS1 DEGS1 1410/4885NR1H4 747/4885PLG 3673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.